Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lambert-Eaton Myasthenic Syndrome

• Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
• Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
• Expanded Access Study Amifampridine Phosphate in Congenital Myasthenic Syndrome (CMS)
• Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
• 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
• Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
• Treatment Use of 3,4-Diaminopyridine
• Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
• Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
• A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
• Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
• Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
• Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
• 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Treatment of Lambert-Eaton Syndrome With 3,4 DAP
• Ephedrine for the Treatment of Congenital Myasthenia
• Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome